“Lebrikizumab Improves Atopic Dermatitis in Adult and Adolescent Patients With Skin of Color: 16-Week Results From the ADmirable Study”. SKIN The Journal of Cutaneous Medicine 9, no. 1 (January 13, 2025): s515. Accessed May 24, 2026. https://skin.dermsquared.com/skin/article/view/3149.